SC
IDYA icon

SummitTX Capital’s IDEAYA Biosciences IDYA Stock Holding History

SummitTX Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.64M Buy
204,872
+42,139
+26% +$1.29M 0.2% 132
2026
Q1 		$5.42M Buy
+162,733
New +$5.46M 0.17% 146
2025
Q4 		– Sell
-164,992
Closed -$4.49M – 823
2025
Q3 		$4.49M Sell
164,992
-42,217
-20% -$1.02M 0.19% 125
2025
Q2 		$4.36M Buy
207,209
+74,786
+56% +$1.43M 0.19% 137
2025
Q1 		$2.17M Buy
+132,423
New +$2.82M 0.09% 233

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SummitTX Capital's IDYA Position: Q2 2026 in Review

SummitTX Capital increased its IDEAYA Biosciences (IDYA) stake by 26% in Q2 2026, buying an estimated $1.29M and bringing the position to 204,872 shares worth $7.64M. The position accounts for 0.2% of the portfolio, ranked #132.

SummitTX Capital first reported a position in IDYA in Q1 2025 and has held it in 5 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • SummitTX Capital held 204,872 shares of IDEAYA Biosciences worth $7.64M as of Q2 2026.
  • SummitTX Capital bought 42,139 IDEAYA Biosciences shares in Q2 2026, an estimated $1.29M.
  • IDEAYA Biosciences made up 0.2% of SummitTX Capital's portfolio in Q2 2026, its #132 holding.
  • SummitTX Capital first reported a position in IDEAYA Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.